Enpp-1-IN-4
Enpp-1-IN-4 is a potent inhibitor of ectonucleotide pyrophosphatase-phosphodiesterase 1 (enpp-1) . Enpp-1-IN-4 has the potential for the research of cancer diseases (extracted from patent WO2019177971A1, compound 1) [1].
Product Specifications
CAS Number
[2376600-89-2]
UNSPSC
12352005
Target
Phosphodiesterase (PDE)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/enpp-1-in-4.html
Solubility
10 mM in DMSO
Smiles
O=C1NC2=CN=C3C=C(C(OC)=CC3=C2N1CC4=CC=C(NS(=O)(N)=O)C=C4)OC
Molecular Formula
C19H19N5O5S
Molecular Weight
429.45
References & Citations
[1]William Michael Gallatin, et al. Ectonucleotide pyrophosphatase-phosphodiesterase 1 (enpp-1) inhibitors and uses thereof. Patent WO2019177971A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
Huntingtin Protein, aa1844-2131 (Huntington Disease) (MaxLight 650)
Huntingtin Protein, aa1844-2131 (Huntington Disease) (MaxLight 650)
Recombinant Shigella dysenteriae serotype 1 UPF0283 membrane protein YcjF (ycjF)